Variant report
Variant | nsv1008459 |
---|---|
Chromosome Location | chr2:49041121-49062097 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:48996460..48999048-chr2:49041792..49043593,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527973635 | chr2:49041154-49041155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184026887 | chr2:49041267-49041268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147374974 | chr2:49041270-49041271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533254024 | chr2:49041277-49041278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550428183 | chr2:49041278-49041279 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148017982 | chr2:49041299-49041300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7603311 | chr2:49041322-49041323 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs189603150 | chr2:49041347-49041348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548689921 | chr2:49041361-49041362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572408067 | chr2:49041369-49041370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113189368 | chr2:49041392-49041393 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181606110 | chr2:49041418-49041419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555650543 | chr2:49041500-49041501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186957080 | chr2:49041568-49041569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141731871 | chr2:49041573-49041574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs111740534 | chr2:49041614-49041615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577307948 | chr2:49041621-49041622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76669415 | chr2:49041738-49041739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559846314 | chr2:49041743-49041744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536503560 | chr2:49041763-49041764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139599494 | chr2:49041822-49041823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114589227 | chr2:49041858-49041859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143499337 | chr2:49041892-49041893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532080447 | chr2:49041954-49041955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374451683 | chr2:49041968-49041969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112600590 | chr2:49042003-49042004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571918334 | chr2:49042030-49042031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs71407524 | chr2:49042031-49042032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569494481 | chr2:49042032-49042033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532605094 | chr2:49042052-49042053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146293641 | chr2:49042084-49042085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs139490892 | chr2:49042087-49042088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs13025362 | chr2:49042131-49042132 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs144221909 | chr2:49042219-49042220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567536262 | chr2:49042241-49042242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs60324887 | chr2:49042243-49042244 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs145246817 | chr2:49042299-49042300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541727682 | chr2:49042359-49042360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567094808 | chr2:49042394-49042395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9636432 | chr2:49042399-49042400 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs577417605 | chr2:49042465-49042466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs71399089 | chr2:49042485-49042486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs13026157 | chr2:49042486-49042487 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs148744844 | chr2:49042488-49042489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs13026374 | chr2:49042517-49042518 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs560765580 | chr2:49042550-49042551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs72811860 | chr2:49042555-49042556 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs544133111 | chr2:49042565-49042566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190588087 | chr2:49042568-49042569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142382319 | chr2:49042594-49042595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:48994600-49080200 | Weak transcription | Stomach Smooth Muscle | stomach |
2 | chr2:49037200-49045400 | Weak transcription | Ovary | ovary |
3 | chr2:49039800-49043600 | Weak transcription | Fetal Intestine Large | intestine |
4 | chr2:49040400-49041200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
5 | chr2:49041200-49041400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr2:49042400-49042600 | Enhancers | Fetal Intestine Small | intestine |
7 | chr2:49042600-49043400 | Weak transcription | Fetal Intestine Small | intestine |
8 | chr2:49043400-49045600 | Enhancers | Fetal Intestine Small | intestine |
9 | chr2:49043600-49047000 | Enhancers | Fetal Intestine Large | intestine |
10 | chr2:49045400-49045800 | Enhancers | Ovary | ovary |
11 | chr2:49045800-49046000 | Weak transcription | Ovary | ovary |
12 | chr2:49046000-49046600 | Enhancers | Ovary | ovary |
13 | chr2:49046200-49047000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr2:49046200-49047800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
15 | chr2:49046600-49053200 | Weak transcription | Ovary | ovary |
16 | chr2:49054000-49054400 | Enhancers | Fetal Intestine Large | intestine |
17 | chr2:49055200-49056000 | Enhancers | NH-A | brain |
18 | chr2:49055200-49056400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
19 | chr2:49055200-49056600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
20 | chr2:49055400-49056000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
21 | chr2:49055800-49056200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
22 | chr2:49055800-49056200 | Enhancers | Osteobl | bone |
23 | chr2:49062000-49062400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |